Geography, phase, indication, budget, timelines, and specialist dependencies should shape the first vendor cut.
Selection guide
Clinical vendor selection should be a shortlist process, not a popularity contest.
Strong vendor selection starts with the study need, then compares vendors against delivery risk, operating fit, and evidence. Weak vendor selection starts with brand recognition and works backwards.
Vendor capability lists are not enough. Sponsors need to understand how the programme will really be delivered.
Public operating context, platform reviews, and structured comparison are more useful than brand familiarity alone.
The right shortlist is defendable. Teams should be able to explain why each vendor is there and what risk it offsets.
Common mistakes
- Starting with the biggest CRO names rather than the actual programme need.
- Skipping specialist vendor dependencies until late in the process.
- Confusing procurement convenience with execution fit.
Better practice
- Screen by category, region, and study complexity first.
- Use evidence to compare the shortlist rather than intuition alone.
- Bring sponsor support in earlier when the shortlist or bid process is weak.
Use CVC
Start with the directory, then move into shortlist support.
Related guides
Best CRO for biotechBest CRO for oncology
Best central lab for clinical trials
FAQ
What is clinical vendor selection?
It is the process of building and testing a shortlist of CROs, labs, eClinical vendors, biometrics teams, and other providers against study fit and execution risk.
What is the biggest mistake in vendor selection?
A common mistake is starting with familiar vendor names instead of the actual study need, delivery model, and specialist dependencies.